Dr Verstraeten is the founder of P95, a team of 15 epidemiologists, statisticians and analysts located across the globe. With his team, he provides epidemiology and pharmacovigilance support to all stakeholders in vaccination, including industry, public health and academia. His research interests include pharmaco-epidemiology, biostatistics, and vaccinology in general. Recent projects he was involved in include meta-analyses of the safety and effectiveness of vaccines, quantitative benefit-risk assessment in both development and post-licensure application and modelling the burden of infectious diseases in large electronic databases. Prior to founding P95, Dr Verstraeten worked at the CDC as an EIS officer in the vaccine safety branch and was the head of the epidemiology and pharmacovigilance departments of GSK’s vaccine division.